Lexington, KY, United States of America

Amber Taraska

This inventor holds 1 USPTO granted patent. Top assignee: Brady Worldwide Corp.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Amber Taraska

Introduction

Amber Taraska is a notable inventor based in Lexington, KY (US). She has made significant contributions to the field of fluid ejection technology. With a focus on enhancing the efficiency of fluid ejection heads, her work has implications for various applications in technology and manufacturing.

Latest Patents

Amber holds a patent for an innovative design titled "Ejection head nozzle flooding control." This patent describes a nozzle plate configured for a fluid ejection head, which includes a method for modifying the nozzle plate to reduce fluid flooding. The design features a plurality of nozzle holes attached to a flow feature layer on a semiconductor substrate. Additionally, it incorporates a first hydrophobic region surrounding each nozzle hole, effectively reducing flooding on the nozzle plate.

Career Highlights

Amber Taraska is currently employed at Brady Worldwide Corporation, where she continues to develop her expertise in fluid ejection technologies. Her work at Brady has allowed her to apply her innovative ideas in a practical setting, contributing to the company's advancements in the field.

Collaborations

Some of her notable coworkers include David L. Bernard and Adam D. Carrithers. Their collaboration has fostered a creative environment that encourages innovation and the development of new technologies.

Conclusion

Amber Taraska's contributions to fluid ejection technology exemplify the impact of innovative thinking in engineering. Her patent and work at Brady Worldwide Corporation highlight her role as a leading inventor in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…